Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.83
+0.44
(+5.95%)
USD |
NASDAQ |
Feb 06, 16:00
7.84
+0.01
(+0.13%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 92.15M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -274.14M |
| Curis, Inc. | -14.69M |
| LadRx Corp. | -2.135M |
| Plus Therapeutics, Inc. | 5.054M |
| Windtree Therapeutics, Inc. | -11.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.51M |
| Total Liabilities (Quarterly) | 17.37M |
| Debt to Equity Ratio | 0.0222 |
| Current Ratio | 6.306 |
| Net Debt Paydown Yield | 1.61% |